about
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American CoReview of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Oral antiplatelet therapy for acute ischaemic strokeMultiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackAntiplatelet therapy for acute ischaemic strokeAntiplatelet therapy for aneurysmal subarachnoid haemorrhageAntiplatelet therapy for acute ischaemic strokeProtease-activated receptors 1 and 4 mediate activation of human platelets by thrombinInteraction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosaAntiplatelet and anticoagulant therapy in elective percutaneous coronary interventionRisk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulationsNew Therapeutic Approaches in Polycythemia VeraAntithrombotic drugs: pharmacology and implications for dental practiceSingle oral dose study of two isosorbide-based aspirin prodrugs in the dogGiving aspirin and ibuprofen after myocardial infarctionInhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirinAntithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonistAntiplatelet therapy in cardiovascular diseaseNonprescription analgesics and their use in solid-organ transplantation: a reviewA comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and womenThe role of antiplatelet therapy in the management of acute coronary syndromesRegular or "super-aspirins"? A review of thienopyridines or aspirin to prevent strokeCyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outsIndividual dosing of ASA prophylaxis by controlling platelet aggregationDeterminants of the interindividual variability in response to antiplatelet drugsVasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive ratsPurpura due to aspirin-induced platelet dysfunction aggravated by drinking alcoholAssociation between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studiesLumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjectsCombined aspirin/ACE inhibitor treatment for CHFPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinFlow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass graftingPotential cardioprotective actions of no-releasing aspirinUpper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?Is aspirin effective in diabetic patients? YesAspirin dose for prevention of cardiovascular disease in diabeticsPrior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophilsLow molecular weight heparin in immunological recurrent abortion--the incredible cureAntagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administrationDifferences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers
P2860
Q22241289-1BD01FC8-A33D-412C-867F-79E96560144BQ22241777-C5A557C0-CA3B-4AC2-BEFC-C5562D72110DQ24197866-DE481D6D-4B72-4D92-97CE-FD8E3263BE7DQ24201386-658EA98F-5A9C-40A0-8AAC-AF8F44CCC232Q24242725-FA9BD142-EA66-4E6C-A2A9-BA68832CB8E8Q24243050-F5E2B0CD-E180-4141-834C-EA7B3FB3A53AQ24248787-7A51BA95-FBCD-4AA6-92AB-07F8FC8FEE9AQ24563384-A020E732-895D-413E-99E4-45D4DAB96ECDQ24685768-6EAADB95-DA1F-4E21-BFE4-69580C927B22Q24793199-6B10A905-382C-4BE4-8899-DD2FEE879857Q24798492-0AB24234-59CA-4671-B24F-C03970C9584DQ26795677-6F62ABC4-D048-49B3-95BC-75EAB8B347E1Q26852932-02A6E8B1-D61E-48D8-9F4E-9025AC9A861AQ28166016-5ECCB5CF-9BFE-4809-AC98-FFDE96458DF8Q28166360-372DB0E5-4D4E-44B7-8B66-702F87B866D0Q28166708-C0D7165F-77DE-43E7-B67D-CE462F310392Q28167658-E787B9AF-078A-4CAB-A67B-DD4C21745069Q28167737-470049EA-07BC-423C-9BE9-E1E92A196434Q28171237-FDA4D785-E36F-4123-8025-3B9E5100DCA3Q28176072-215C5197-1B79-4A85-A3E9-9A82C1CF75A6Q28176548-38585ED0-DB66-45CA-97C8-AA0EAEBCF9E3Q28183391-FD53D6E2-6977-4E43-9526-69334E1C67FBQ28186050-87E14622-ECB8-4DC2-A79A-FFC2957BF549Q28186213-94A0BCC7-E0C5-45AC-B6F5-4FEA2F7D4D75Q28187591-29B30CAE-B253-487D-9FCE-A0BB5E3B4FA9Q28187870-682FBB15-5EE7-41DE-B78B-148DE9F1B3D9Q28190677-4AC31244-611D-445F-8D7D-A6CD7C7EF5F3Q28191843-1E94E19E-4042-49DF-87A8-127898B91945Q28192026-6417B447-5F7F-46F2-84DF-6D13E4C0C2D6Q28192122-2FF06E08-63EC-4426-ADA0-C12C5D5C505DQ28192701-650CCF84-CDEB-4AF4-9AFE-4351813DBA2AQ28192855-73848DC6-5EB8-47FC-8B6E-A166A4F86164Q28193422-240B447D-F878-4EF7-BED2-398848CA12DCQ28193564-84C10243-3372-4189-BD73-E319358E3ACDQ28193977-9700D7FA-DA35-4933-8B09-938EF7343F1DQ28194526-898C0C64-0129-4823-AEFF-8616A30E77A9Q28194671-59A75842-8B09-4DB3-91FA-73AAD91A8708Q28195646-47DD51BF-7660-4CBD-BDD7-A609EF53F4E9Q28196386-399A91F6-1426-4D40-85B4-D4CC677BB701Q28196435-26C79788-9FB9-4771-80E0-E7296E275BD8
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Aspirin as an antiplatelet drug.
@ast
Aspirin as an antiplatelet drug.
@en
Aspirin as an antiplatelet drug.
@nl
type
label
Aspirin as an antiplatelet drug.
@ast
Aspirin as an antiplatelet drug.
@en
Aspirin as an antiplatelet drug.
@nl
prefLabel
Aspirin as an antiplatelet drug.
@ast
Aspirin as an antiplatelet drug.
@en
Aspirin as an antiplatelet drug.
@nl
P1476
Aspirin as an antiplatelet drug.
@en
P2093
P304
P356
10.1056/NEJM199405053301808
P407
P577
1994-05-01T00:00:00Z